Ectodomain shedding of Fcalpha receptor is mediated by ADAM10 and ADAM17.

Min Peng,Sha Guo,Na Yin,Jing Xue,Lian Shen,Qing Zhao,Wei Zhang
DOI: https://doi.org/10.1111/j.1365-2567.2009.03215.x
2010-01-01
Immunology
Abstract:P>Fc alpha R (CD89) plays important roles in immunoglobulin A (IgA)-mediated immune responses. Soluble forms of Fc alpha R (sFc alpha R) are found in the culture supernatants of Fc alpha R-expressing cells, in human serum and in the serum of Fc alpha R transgenic mice, and have been suggested to be produced through a proteolytic process. However, little is known about the mechanism involved in the proteolytic release of sFc alpha R. In this study, we investigated the shedding mechanism of Fc alpha R and determined the nature of the proteinase involved in Fc alpha R shedding. In chemical inhibitor assays, shedding of Fc alpha R was dramatically inhibited by EDTA, EGTA and a broad-spectrum metalloproteinase inhibitor, GM6001, suggesting that a metalloproteinase was responsible for Fc alpha R shedding. Overexpression of dominant-negative mutants of ADAM (a disintegrin and metalloproteinase) 10 and ADAM17 markedly inhibited the production of sFc alpha R. Finally, knockdown of both endogenous ADAM10 and endogenous ADAM17 inhibited Fc alpha R shedding, demonstrating that ADAM10 and ADAM17 were involved in the shedding of Fc alpha R. The characterization of ADAM10 and ADAM17 as sFc alpha R-releasing enzymes provides a novel insight into the molecular mechanism of sFc alpha R production and will help in further elucidation of the physiological and pathological roles of sFc alpha R.
What problem does this paper attempt to address?